Cost-Utility Analysis of TAVI Versus Surgery in Low-Risk Patients with Severe Aortic Stenosis in the UK [0.03%]
低危患者的主动脉瓣狭窄经导管主动植入术与手术的费用效益分析（英国）
Nick Curzen,Pascal Candolfi,Philip MacCarthy et al.
Nick Curzen et al.
Background and objective: European guidelines recommend transcatheter aortic valve implantation (TAVI; class IA) for symptomatic severe aortic stenosis (sSAS) in patients aged ≥ 75 years, if a transfemoral approach is po...
Budget Impact Analysis of Implementing C-Reactive Protein Point-of-Care Testing to Aid Antibiotic Prescribing in Belgian Primary Care [0.03%]
在比利时初级保健中实施C-反应蛋白现场检测辅助抗生素处方的预算影响分析
Salima Azahaf,Erinn D&#x;hulster,Margo Van Genechten et al.
Salima Azahaf et al.
Background: The inappropriate use of antibiotics is a key driver of antimicrobial resistance (AMR) and can lead to various adverse side effects. C-reactive protein (CRP) point-of-care testing (POCT) in primary care has sh...
Which Factors are Holding up the Integration of the Environmental Impact of Health Technologies in Health Technology Assessment? Insights from a Multi-Stakeholder Interview Study [0.03%]
哪些因素阻碍了环境影响评估在健康技术评估中的整合？来自多利益相关者访谈研究的启示
Vittoria Ardito,Helen Banks,Rosanna Tarricone
Vittoria Ardito
Objectives: The integration of environmental impact into health technology assessment (HTA) is increasingly discussed, but its practical implementation remains uncertain. This study explores multi-stakeholder perspectives...
Health Technology Assessment Guidelines and Recommendations Across European Union Countries and the United Kingdom in Rare Disease and Paediatric Populations [0.03%]
欧洲联盟及英国罕见病和儿科人群卫生技术评估指南和推荐措施
Adéla Bártová,Jiří Samek,Vera Pinheiro et al.
Adéla Bártová et al.
Objectives: Due to limited clinical data, high uncertainty, and outcome variability, assessing therapies for paediatric and rare disease populations poses specific challenges, often requiring adjustments to standard healt...
Opportunities for CMS to Further Specify and Broaden Its Approach to Assessing Unmet Medical Need in the Context of the Medicare Drug Price Negotiation Program [0.03%]
《关于在医疗保险药物价格谈判计划背景下进一步明确和扩大评估未满足的医疗需求的方法的机会》
Michael J DiStefano,R Brett McQueen,Hanke Zheng et al.
Michael J DiStefano et al.
The United States Inflation Reduction Act of 2022 established the Medicare Drug Price Negotiation Program, directing the Centers for Medicare and Medicaid Services (CMS) to establish "maximum fair prices" for select drugs. In arriving at ma...
The Role of Price Variation in Economic Analyses for Cancer Screenings: A Rapid Review [0.03%]
价格波动在癌症筛查经济分析中的作用：快速回顾型系统评价
Austin J Triana,Mason N Alford-Holloway
Austin J Triana
Background: Health care spending continues to rise, and recent policies have made prices more visible. Purpose: To assess how cost effe...
Burden of Disease in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Scoping Review [0.03%]
肌痛性脑脊髓炎/慢性疲劳综合征(ME/CFS)疾病负担的系统综述研究
Patricia Vester,Stefanos Boudouroglou-Walter,Jonas Schreyögg et al.
Patricia Vester et al.
Objective: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a serious chronic and complex multi-system disease characterised by symptoms such as post-exertional malaise, fatigue, cognitive impairment and pai...
Aligning Indigenous and Western Concepts of Health Resource Decision Making in a Western Canadian First Nations Context [0.03%]
从西加拿大原住民的视角看健康资源配置的西方观点和印第安土著观点的结合
Aidan Neill,Stephanie Montesanti,Lea Bill et al.
Aidan Neill et al.
Background: Western health economic evaluation tools often fail to reflect the relational, collective, and holistic perspectives that underpin Indigenous concepts of health. These limitations pose challenges when applying...
Willingness to Pay per QALY: A Systematic Review of Demand-Side Valuations with a Focus on Age and Disease Severity [0.03%]
基于需求的QALY支付意愿评估的系统综述：重点关注年龄和疾病严重程度的影响
Marios Athanasios Loupas,Kostas Athanasakis,Dimitris Zavras
Marios Athanasios Loupas
Background: Willingness-to-pay (WTP) studies offer a demand-side perspective on the monetary value of health gains, typically expressed as WTP per quality-adjusted life year (WTP/Q). These estimates can complement supply-...
A Systematic Review of Economic Evaluations on Interventions Targeting Insomnia or Hypersomnia [0.03%]
改善失眠或嗜睡的干预措施的经济学评价系统综述
Phuong Hong Le,Long Khanh-Dao Le,Dai Quy Le et al.
Phuong Hong Le et al.
Objective: Insomnia and hypersomnia are sleep conditions associated with significant costs to the healthcare system and society. This study aimed to review the cost-effectiveness evidence of interventions for insomnia and...